Free Trial

Clever Leaves (CLVR) Competitors

Clever Leaves logo

CLVR vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Clever Leaves vs.

180 Life Sciences (NASDAQ:ATNFW) and Clever Leaves (NASDAQ:CLVR) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Given Clever Leaves' higher possible upside, analysts clearly believe Clever Leaves is more favorable than 180 Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Clever Leaves
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Clever Leaves received 13 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Clever LeavesOutperform Votes
13
81.25%
Underperform Votes
3
18.75%

180 Life Sciences has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$11.31N/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Clever Leaves N/A N/A N/A

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Clever Leaves had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Clever Leaves and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Clever Leaves Neutral

Summary

Clever Leaves beats 180 Life Sciences on 6 of the 6 factors compared between the two stocks.

Get Clever Leaves News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVR vs. The Competition

MetricClever LeavesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$7.03B$5.40B$8.53B
Dividend YieldN/A7.96%5.13%4.14%
P/E RatioN/A9.93115.5615.18
Price / SalesN/A381.421,484.3492.77
Price / CashN/A47.3439.6634.07
Price / BookN/A5.324.665.02
Net Income-$17.90M$153.56M$119.06M$225.46M

Clever Leaves Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVR
Clever Leaves
N/AN/AN/AN/A$0.00$17.42M0.00560Gap Down
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-9.1%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
+17.8%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$65,122.000.0040Positive News
ALVOW
Alvotech
N/A$3.20
+5.3%
N/AN/A$0.00$306.77M0.004Positive News
ALVO
Alvotech
2.0875 of 5 stars
$13.02
+0.3%
$18.00
+38.2%
+51.6%$0.00$93.38M-4.911,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004Positive News
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$12.54
flat
N/A+19.1%$0.00N/A0.004Positive News
Gap Up
BFRIW
Biofrontera
N/A$0.07
-64.6%
N/A+119.3%$0.00$35.24M0.0070Gap Down
High Trading Volume
BTMDW
biote
N/A$0.56
-5.1%
N/A-46.8%$0.00$187.23M0.00N/AGap Up

Related Companies and Tools


This page (NASDAQ:CLVR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners